241 related articles for article (PubMed ID: 33198344)
1. Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer.
Ogihara T; Mizoi K; Kamioka H; Yano K
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33198344
[TBL] [Abstract][Full Text] [Related]
2. Correlations of mRNA Levels among Efflux Transporters, Transcriptional Regulators, and Scaffold Proteins in Non-Small-Cell Lung Cancer.
Zhang X; Liu W; Edaki K; Nakazawa Y; Kamioka H; Fujita A; Onozato R; Iijima M; Tsuchida S; Arai T; Fujita Y; Mizoi K; Ogihara T
Can J Infect Dis Med Microbiol; 2021; 2021():4005327. PubMed ID: 34876945
[TBL] [Abstract][Full Text] [Related]
3. Regulation of breast cancer resistance protein and P-glycoprotein by ezrin, radixin and moesin in lung, intestinal and renal cancer cell lines.
Yano K; Okabe C; Fujii K; Kato Y; Ogihara T
J Pharm Pharmacol; 2020 Apr; 72(4):575-582. PubMed ID: 31975441
[TBL] [Abstract][Full Text] [Related]
4. Moesin-Mediated P-Glycoprotein Activation During Snail-Induced Epithelial-Mesenchymal Transition in Lung Cancer Cells.
Kamioka H; Tomono T; Fujita A; Onozato R; Iijima M; Tsuchida S; Arai T; Fujita Y; Zhang X; Yano K; Ogihara T
J Pharm Sci; 2020 Jul; 109(7):2302-2308. PubMed ID: 32173323
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance via radixin-mediated increase of P-glycoprotein membrane expression during SNAI1-induced epithelial-mesenchymal transition in HepG2 cells.
Kamioka H; Edaki K; Kasahara H; Tomono T; Yano K; Ogihara T
J Pharm Pharmacol; 2021 Dec; 73(12):1609-1616. PubMed ID: 34313784
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of Induction of P-gp Activity During MET Induced by DEX in Lung Cancer Cell Line.
Liu W; Zhang X; Sunakawa H; Perera LMB; Martha L; Mizoi K; Ogihara T
J Pharm Sci; 2024 Jun; 113(6):1674-1681. PubMed ID: 38432625
[TBL] [Abstract][Full Text] [Related]
7. Slug Mediates MRP2 Expression in Non-Small Cell Lung Cancer Cells.
Zhang X; Liu W; Edaki K; Nakazawa Y; Takahashi S; Sunakawa H; Mizoi K; Ogihara T
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740931
[TBL] [Abstract][Full Text] [Related]
8. Snail-Induced Epithelial-to-Mesenchymal Transition Enhances P-gp-Mediated Multidrug Resistance in HCC827 Cells.
Tomono T; Yano K; Ogihara T
J Pharm Sci; 2017 Sep; 106(9):2642-2649. PubMed ID: 28322937
[TBL] [Abstract][Full Text] [Related]
9. Advances in Studies of P-Glycoprotein and Its Expression Regulators.
Yano K; Tomono T; Ogihara T
Biol Pharm Bull; 2018; 41(1):11-19. PubMed ID: 29311472
[TBL] [Abstract][Full Text] [Related]
10. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
Assaraf YG
Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
[TBL] [Abstract][Full Text] [Related]
11. The Role of CD44 and ERM Proteins in Expression and Functionality of P-glycoprotein in Breast Cancer Cells.
Pokharel D; Padula MP; Lu JF; Jaiswal R; Djordjevic SP; Bebawy M
Molecules; 2016 Mar; 21(3):290. PubMed ID: 26938523
[TBL] [Abstract][Full Text] [Related]
12. The effect of radixin knockdown on the expression and efflux function of MRP2 in SGC-7901 cells.
He XJ; Wang WR; Zhang Y; Yang Q
Eur J Pharm Sci; 2012 Aug; 46(5):426-34. PubMed ID: 22469515
[TBL] [Abstract][Full Text] [Related]
13. Different regulation of P-glycoprotein function between Caco-2 and Caki-1 cells by ezrin, radixin and moesin proteins.
Yano K; Otsuka K; Kato Y; Kawabata H; Ohmori S; Arakawa H; Ogihara T
J Pharm Pharmacol; 2016 Mar; 68(3):361-7. PubMed ID: 26888084
[TBL] [Abstract][Full Text] [Related]
14. NHERF1/EBP50 as a Target for Modulation of MRP Function in HepG2 Cells.
Kawase A; Hirosoko M; Sugihara Y; Koyama Y; Fukae A; Shimada H; Iwaki M
Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33800412
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of moesin in breast cancers and its implication in epithelial-mesenchymal transition.
Wang CC; Liau JY; Lu YS; Chen JW; Yao YT; Lien HC
Histopathology; 2012 Jul; 61(1):78-87. PubMed ID: 22439598
[TBL] [Abstract][Full Text] [Related]
16. [Expression of ABCG2 and p-glycoprotein in residual breast cancer tissue after chemotherapy and their correlation with epithelial-mesenchymal transition].
Qu H; Fang L; Duan L; Long X
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):236-40. PubMed ID: 24915813
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance in breast cancer cells during epithelial-mesenchymal transition is modulated by breast cancer resistant protein.
Chen WJ; Wang H; Tang Y; Liu CL; Li HL; Li WT
Chin J Cancer; 2010 Feb; 29(2):151-7. PubMed ID: 20109342
[TBL] [Abstract][Full Text] [Related]
18. Involvement of moesin in the development of morphine analgesic tolerance through P-glycoprotein at the blood-brain barrier.
Kobori T; Fujiwara S; Miyagi K; Harada S; Nakamoto K; Nakagawa T; Takahashi H; Narita M; Tokuyama S
Drug Metab Pharmacokinet; 2014; 29(6):482-9. PubMed ID: 25048710
[TBL] [Abstract][Full Text] [Related]
19. Radixin knockdown improves the accumulation and efficiency of methotrexate in tumor cells.
Kawase A; Inoue Y; Nakazaki S; Koizumi E; Iwaki M
Oncol Rep; 2019 Jul; 42(1):283-290. PubMed ID: 31115547
[TBL] [Abstract][Full Text] [Related]
20. Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells.
Buckley ST; Medina C; Kasper M; Ehrhardt C
Am J Physiol Lung Cell Mol Physiol; 2011 Apr; 300(4):L548-59. PubMed ID: 21278261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
